Gilbert Custer
Psychiatry · Austin, TXNPI 1376554196
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 291 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,950 and has fallen 92.3% since, to $150 in 2022.
Across 291 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$841
- AbbVie$688
- Takeda Pharmaceuticals U.S.A., Inc.$411
- Arbor Pharmaceuticals, Inc.$318
- Sunovion Pharmaceuticals Inc.$276
- Vanda Pharmaceuticals Inc.$262
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,373100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 48 | $841 |
| AbbVie(2 entities) | 68 | $688 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $411 |
| Arbor Pharmaceuticals, Inc. | 21 | $318 |
| Sunovion Pharmaceuticals Inc. | 22 | $276 |
| Vanda Pharmaceuticals Inc. | 16 | $262 |
| Ironshore Pharmaceuticals Inc. | 15 | $220 |
| Lundbeck LLC | 8 | $157 |
| Shire North American Group Inc | 10 | $156 |
| Adlon Therapeutics L.p. | 8 | $140 |
| Neos Therapeutics, LP | 8 | $125 |
| Jazz Pharmaceuticals Inc. | 7 | $116 |
| Eisai Inc. | 6 | $105 |
| Bausch Health US, LLC | 4 | $96 |
| Johnson & Johnson | 5 | $85 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $72 |
| Avanir Pharmaceuticals, Inc. | 5 | $72 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| Neurocrine Biosciences, Inc. | 3 | $50 |
| Alkermes, Inc. | 2 | $42 |
| Tris Pharma Inc | 2 | $35 |
| Validus Pharmaceuticals LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Merck | 1 | $12 |
| OWP Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,373 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Austin
- Arvinder Pal WaliaAustin$2.5M
- Charles NemeroffAustin$429K
- Divyansu PatelAustin$50K
- Rakesh JainLake Jackson$7.2M
- Suresh SureddiPlano$2.2M
- Martin GuerreroEl Paso$2M
- Marty BennettAddison$1.8M
- Matthew BramsHouston$1.5M
- Vikram MehraKaty$1.2M
- Joel HolinerDallas$948K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.